DRKS00024134已完成未知

Prospective evaluation of the DEtection rate of clinically significant PROstate cancer by mpMRI and PSMA-PET/CT fusion biopsy - DEPROMP

Klinik und Poliklinik für Urologie und Kinderurologie Universitätsklinikum Bonn0 个研究点目标入组 246 人开始时间: 2021年1月26日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•The patient is suspected of having a localised prostate carcinoma based on at least one of the following criteria, so that clarification by means of MRI fusion punch biopsy is indicated:
•PSA-value = 4 ng/ml or
•suspicious tactile findings of the prostate in the digital rectal examination or
•suspicious findings in transrectal sonography
•patients must be = 45 years and < 76 years old
•patients must be biopsy-naive
•patient gives documented written consent to participate in the study
•patients who are able to follow the study instructions and who are likely to adhere to all required study visits (compliance)

•The patient has a PSA level elevation of >100 ng/ml with resulting suspicion of advanced metastatic prostate carcinoma
•The patient has a serious kidney disease, defined by Estimated creatinine clearance < 30 ml/min (using a site-specific method)

发起方

Klinik und Poliklinik für Urologie und Kinderurologie Universitätsklinikum Bonn